146 related articles for article (PubMed ID: 35259199)
21. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
22. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
[TBL] [Abstract][Full Text] [Related]
23. Quantitative assessment of dynamic
Tau N; Berlin A; Yeung I; Halankar J; Murphy G; Jhaveri KS; Ghai S; Metser U
Br J Radiol; 2019 Feb; 92(1094):20180568. PubMed ID: 30383459
[TBL] [Abstract][Full Text] [Related]
24. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses.
Ng CS; Raunig DL; Jackson EF; Ashton EA; Kelcz F; Kim KB; Kurzrock R; McShane TM
AJR Am J Roentgenol; 2010 Feb; 194(2):W134-40. PubMed ID: 20093564
[TBL] [Abstract][Full Text] [Related]
25. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
26. Imaging of Carotid Plaque Neovascularization by Contrast-Enhanced Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Cattaneo M; Sun J; Staub D; Xu D; Gallino JM; Santini P; Porretta AP; Yuan C; Balu N; Arnold M; Froio A; Limoni C; Wyttenbach R; Gallino A
Cerebrovasc Dis; 2019; 48(3-6):140-148. PubMed ID: 31661690
[TBL] [Abstract][Full Text] [Related]
27. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
28. Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.
Gaustad JV; Simonsen TG; Smistad R; Wegner CS; Andersen LM; Rofstad EK
BMC Cancer; 2015 Nov; 15():900. PubMed ID: 26573613
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions.
Kang Y; Hong EK; Rhim JH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SW; Choi SH
Korean J Radiol; 2020 Jun; 21(6):707-716. PubMed ID: 32410409
[TBL] [Abstract][Full Text] [Related]
30. Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparison.
Nguyen VL; Kooi ME; Backes WH; van Hoof RH; Saris AE; Wishaupt MC; Hellenthal FA; van der Geest RJ; Kessels AG; Schurink GW; Leiner T
PLoS One; 2013; 8(10):e75173. PubMed ID: 24098370
[TBL] [Abstract][Full Text] [Related]
31. Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI.
Jones KM; Pagel MD; Cárdenas-Rodríguez J
Magn Reson Imaging; 2018 Apr; 47():16-24. PubMed ID: 29155024
[TBL] [Abstract][Full Text] [Related]
32. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.
Yankeelov TE; Luci JJ; Lepage M; Li R; Debusk L; Lin PC; Price RR; Gore JC
Magn Reson Imaging; 2005 May; 23(4):519-29. PubMed ID: 15919597
[TBL] [Abstract][Full Text] [Related]
33. Quantitative MRI study of the permeability of peritumoral brain edema in lung cancer patients with brain metastases.
Wang D; Wang ML; Li YH
Brain Res; 2017 Aug; 1669():126-130. PubMed ID: 28633995
[TBL] [Abstract][Full Text] [Related]
34. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.
Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR
Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017
[TBL] [Abstract][Full Text] [Related]
35. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma.
Jo SW; Choi SH; Lee EJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Aug; 22(8):1369-1378. PubMed ID: 33987994
[TBL] [Abstract][Full Text] [Related]
37. On the potential use of dynamic contrast-enhanced (DCE) MRI parameters as radiomic features of cervical cancer.
Lu Y; Peng W; Song J; Chen T; Wang X; Hou Z; Yan Z; Koh TS
Med Phys; 2019 Nov; 46(11):5098-5109. PubMed ID: 31523829
[TBL] [Abstract][Full Text] [Related]
38. Influence of different post-contrast time points on dynamic contrast-enhanced (DCE) MRI T staging in breast cancer.
Romeo V; Picariello V; Pignata A; Mancusi V; Stanzione A; Cuocolo R; Di Crescenzo R; Accurso A; Staibano S; Imbriaco M
Eur J Radiol; 2020 Mar; 124():108819. PubMed ID: 31958631
[TBL] [Abstract][Full Text] [Related]
39. Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients.
Klawer EME; van Houdt PJ; Simonis FFJ; van den Berg CAT; Pos FJ; Heijmink SWTPJ; Isebaert S; Haustermans K; van der Heide UA
Magn Reson Med; 2019 May; 81(5):3358-3369. PubMed ID: 30656738
[TBL] [Abstract][Full Text] [Related]
40. T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine.
Guan Y; Peck KK; Lyo J; Tisnado J; Lis E; Arevalo-Perez J; Yamada Y; Hameed MR; Karimi S; Holodny A
Radiology; 2020 Nov; 297(2):382-389. PubMed ID: 32870135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
